Biontech Se Stock Price on March 20, 2024
| BNTX Stock | USD 100.60 1.85 1.87% |
Below is the normalized historical share price chart for BioNTech SE extending back to October 10, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioNTech stands at 100.60, as last reported on the 1st of June, with the highest price reaching 103.57 and the lowest price hitting 98.62 during the day.
If you're considering investing in BioNTech Stock, it is important to understand the factors that can impact its price. BioNTech appears to be very steady, given 3 months investment horizon. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0946, which signifies that the company had a 0.0946% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please makes use of BioNTech's Mean Deviation of 1.54, downside deviation of 1.72, and Risk Adjusted Performance of 0.0541 to double-check if our risk estimates are consistent with your expectations.
At this time, BioNTech's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 24.2 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 185.2 M in 2024. . At this time, BioNTech's Price Book Value Ratio is fairly stable compared to the past year. Price To Operating Cash Flows Ratio is likely to rise to 4.49 in 2024, whereas Price To Sales Ratio is likely to drop 5.71 in 2024. BioNTech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of October 2019 | 200 Day MA 99.3469 | 50 Day MA 91.0536 | Beta 0.255 |
BioNTech |
Sharpe Ratio = 0.0946
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BNTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.26 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average BioNTech is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNTech by adding it to a well-diversified portfolio.
Price Book 0.9584 | Enterprise Value Ebitda 3.057 | Price Sales 5.4571 | Shares Float 89.2 M | Wall Street Target Price 116.26 |
BioNTech Valuation on March 20, 2024
It is possible to determine the worth of BioNTech on a given historical date. On March 20, 2024 BioNTech was worth 88.93 at the beginning of the trading date compared to the closed value of 90.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioNTech stock. Still, in general, we apply an absolute valuation method to find BioNTech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioNTech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioNTech's related companies.
| Open | High | Low | Close | Volume | |
| 92.24 | 94.44 | 92.20 | 94.12 | 569,835 | |
03/20/2024 | 88.93 | 90.11 | 85.21 | 90.00 | 2,964,986 |
| 89.55 | 93.39 | 88.17 | 91.99 | 1,349,370 |
| Backtest BioNTech | | | BioNTech History | | | BioNTech Valuation | Previous | Next |
BioNTech Trading Date Momentum on March 20, 2024
| On March 21 2024 BioNTech SE was traded for 91.99 at the closing time. The top price for the day was 93.39 and the lowest listed price was 88.17 . The trading volume for the day was 1.3 M. The trading history from March 21, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 2.21% . The overall trading delta against the current closing price is 2.63% . |
BioNTech SE Fundamentals Correlations and Trends
By evaluating BioNTech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioNTech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioNTech financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioNTech Stock history
BioNTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioNTech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioNTech SE will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioNTech stock prices may prove useful in developing a viable investing in BioNTech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 242.7 M | 229.1 M | |
| Net Income Applicable To Common Shares | 11.8 B | 12.4 B |
BioNTech Quarterly Net Working Capital |
|
BioNTech Stock Technical Analysis
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioNTech Period Price Range
Low | March 20, 2024
| High |
88.93 | 90.00 |
BioNTech June 1, 2024 Market Strength
Market strength indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By undertsting and applying BioNTech stock market strength indicators, traders can identify BioNTech SE entry and exit signals to maximize returns
BioNTech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioNTech's price direction in advance. Along with the technical and fundamental analysis of BioNTech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioNTech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0541 | |||
| Jensen Alpha | 0.1462 | |||
| Total Risk Alpha | 0.0317 | |||
| Sortino Ratio | 0.0721 | |||
| Treynor Ratio | 0.4248 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share 0.51 | Revenue Per Share 11.369 | Quarterly Revenue Growth (0.85) | Return On Assets (0.01) |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.